Antioxidants are employed to prevent oxidation in a wide range of materials, for example, plastics, elastomers, lubricants, petroleum based products (lubricants, gasoline, aviation fuels, and engine oils), cooking oil, cosmetics, processed food products, and the like. While many antioxidants exist, there is a continuing need for new antioxidants that have improved properties.
The present invention relates to compounds containing dual functionalities of aromatic amines and hindered phenols that can be useful as stabilizers for organic materials, lubricants and petroleum based products, plastics and elastomers, cosmetics, foods and cooking oils, and other materials. In particular, the present invention pertains to highly effective antioxidant macromolecules described herein. This invention also reports an improved, highly efficient and economical process for the synthesis of amine (nitrogen) and sterically hindered phenol containing dual functional macromolecules. The design of macromolecules in this invention can incorporate at least two antioxidant moieties having different reactivities. The present invention also discloses their superior antioxidant performance compared to presently used commercial antioxidants. This is demonstrated especially in both synthetic and petroleum base stocks (Group I, II and III). In general one unique feature and design of the antioxidants described herein is their improved solubility in many commercially available oils and lubricants compared with currently available antioxidants.
In one embodiment the present invention is a compound represented by structural formula (I):
Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl. Each Rc is independently an optionally substituted alkyl or an optionally substituted alkoxycarbonyl. Rx is —H or an optionally substituted alkyl. Ry is —H or an optionally substituted alkyl. Each R′ is independently —H or an optionally substituted alkyl. R″ is —H, an optionally substituted alkyl, an optionally substituted aryl or an optionally substituted aralkyl. n is an integer from 1 to 10. m is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. u is an integer from 1 to 4. With the proviso that when n is 1, then either ring C is not:
s is not 0, or R″ is not —H.
In another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a phenol derivative, an amine and an aldehyde in the presence of a solvent, wherein the phenol derivative comprises at least one unsubstituted ring-carbon atom. Followed by refluxing the combination to produce the compound, and finally isolating the compound.
In yet another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a amino-phenol derivative with an amine in the presence of a solvent, Followed by refluxing the combination to produce the compound, and finally isolating the compound.
In yet another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a phenolic-carbonyl derivative represented by the following structural formula:
with an amine in the presence of a solvent. Followed by refluxing the combination to produce a Schiff's base, reducing the schiff's base with a reducing agent to produce the compound, and finally isolating the compound.
In another embodiment, the present invention is a method of producing a compound represented structural formula (I). The method comprises combining a formaldehyde-sodium bisulfate adduct with an amine to produce a methylsulfonate sodium salt in an aqueous media. Followed by the nucleophilic displacement of the sulfonate group with a sodium or potassium salt of a phenol derivative, in an aqueous media wherein the nucleophilic displacement is catalyzed by base, to produce the compound, and finally isolating the compound.
In another embodiment the present invention is a method of preventing oxidation in an oxidizable material, comprising combining the oxidizable material with a compound of the present invention.
The antioxidants described herein which are prepared by the disclosed processes in general are superior antioxidants (compared to currently available antioxidants) against oxidative, thermal degradation of organic materials. These macromolecular antioxidants generally have comparatively higher antioxidant activities along with improved thermal stability and performance in a wide range of materials including but not limited to plastics, elastomers, lubricants, petroleum based products (lubricants, gasoline, aviation fuels, and engine oils), cooking oil, cosmetics, processed food products.
The processes of the present invention have many advantages which can allow improved synthesis of these macromolecular antioxidants. For example, the disclosed processes can be economically carried out in the melt phase without the presence of catalysts. Moreover, the processes described herein generally reduce or eliminate purification steps for the final product compared to existing syntheses, which can lead to a superior performance/cost ratio for the product and reduced amounts of waste.
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
A description of preferred embodiments of the invention follows.
As used herein, “dual functional” means any molecule with two functional groups which can optionally be the same or in certain embodiment are different, such as amine and hydroxy.
As used herein “adduct” means chemically linked.
Sterically hindered, as used herein means that the substituent group (e.g., bulky alkyl group) on a ring carbon atom adjacent (or para) to a ring carbon atom substituted with a phenolic hydroxy group (or thiol or amine group), is large enough to sterically hinder the phenolic hydroxy group (or thiol or amine groups). This steric hindrance, in certain embodiments results in more labile or weak bonding between the oxygen and the hydrogen (or sulfur or nitrogen and hydrogen) and in turn enhances the stability and antioxidant activity (proton donating activity) of the sterically hindered antioxidant.
Repeat units of the antioxidants of the invention include substituted benzene molecules. Some of these benzene molecules are typically based on phenol or a phenol derivative, such that they have at least one hydroxyl or ether functional group. In certain embodiments, the benzene molecules have a hydroxyl group. The hydroxyl group can be a free hydroxyl group and can be protected or have a cleavable group attached to it (e.g., an ester group). Such cleavable groups can be released under certain conditions (e.g., changes in pH), with a desired shelf life or with a time-controlled release (e.g., measured by the half-life), which allows one to control where and/or when an antioxidant can exert its antioxidant effect. The repeat units can also include analogous thiophenol and aniline derivatives, e.g., where the phenol —OH can be replaced by —SH, —NH—, and the like.
Substituted benzene repeat units of an antioxidant of the invention are also typically substituted with a bulky alkyl group or an n-alkoxycarbonyl group. In certain embodiments, the benzene monomers are substituted with a bulky alkyl group. In certain other embodiments, the bulky alkyl group is located ortho or meta to a hydroxyl group on the benzene ring, typically ortho. A “bulky alkyl group” is defined herein as an alkyl group that is branched alpha- or beta- to the benzene ring. In certain other embodiments, the alkyl group is branched alpha to the benzene ring. In certain other embodiments, the alkyl group is branched twice alpha to the benzene ring, such as in a tert-butyl group. Other examples of bulky alkyl groups include isopropyl, 2-butyl, 3-pentyl, 1,1-dimethylpropyl, 1-ethyl-1-methylpropyl and 1,1-diethylpropyl. In certain other embodiments, the bulky alkyl groups are unsubstituted, but they can be substituted with a functional group that does not interfere with the antioxidant activity of the molecule. Straight chained alkoxylcarbonyl groups include methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, n-butoxycarbonyl and n-pentoxycarbonyl. N-propoxycarbonyl is a preferred group. Similar to the bulky alkyl groups, n-alkoxycarbonyl groups are optionally substituted with a functional group that does not interfere with the antioxidant activity of the molecule.
In one embodiment the present invention is a compound represented by structural formula (I) wherein the variables are as described as follows:
Each Ra is independently an optionally substituted alkyl. In one embodiment, each Ra is independently a C1-C20 alkyl. In another embodiment, each Ra is independently a C1-C10 alkyl. In another embodiment, each Ra is independently selected from the group consisting of:
In another embodiment Ra is:
Each Rb is independently an optionally substituted alkyl.
Each Rc is independently an optionally substituted alkyl or an optionally substituted alkoxycarbonyl. In one embodiment, each Rc is independently a C1-C10 alkyl.
Rx is —H or an optionally substituted alkyl. Ry is —H or an optionally substituted alkyl. In one embodiment, Rx and Ry are —H.
Each R′ is independently —H or an optionally substituted alkyl. In one embodiment, one R′ is —H. In another embodiment, both R′ are —H.
R″ is —H, an optionally substituted alkyl, an optionally substituted aryl or an optionally substituted aralkyl. In one embodiment, R″ is —H, a C1-C20 alkyl or an optionally substituted aralkyl. In another embodiment, R″ is —H, a C1-C10 alkyl or a substituted benzyl group. In yet another embodiment, R″ is —H. In yet another embodiment, R″ is:
In yet another embodiment R″ is selected from the group consisting of:
In yet another embodiment R″ is:
n is an integer from 1 to 10. In one embodiment, n is an integer from 1 to 6. In another embodiment, n is 1. In yet another embodiment, n is 2. In yet another embodiment, n is 3. In yet another embodiment, n is 4.
m is an integer from 1 to 10. In one embodiment, m is 1 or 2. In another embodiment, m is 1.
s is an integer from 0 to 5. In one embodiment, s is 0 or 1. In another embodiment, s is 0.
t is an integer from 0 to 4. In one embodiment, t is 0.
u is an integer from 1 to 4. In one embodiment, u is 1 or 2.
In certain embodiments for compounds of the present invention, including those represented by structural formula (I), when n is 1, the either ring C is not:
s is not 0, or R″ is not —H.
In one embodiment of the present invention for the compounds represented by structural formula (I):
Each Ra is independently a C1-C20 alkyl. Each Rc is independently a C1-C10 alkyl. R″ is —H, a C1-C20 alkyl or an optionally substituted aralkyl, and the remainder of the variables are as described above for structural formula (I).
In another embodiment of the present invention for compounds represented by structural formula (I): one R′ is —H, t is 0, Rx and Ry are —H and the compounds are represented by structural formula (II):
and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I).
In another embodiment of the present invention for the compounds represented by structural formula (II):
m is 1 or 2.
s is 0 or 1.
u is 1 or 2, and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I).
In another embodiment of the present invention for compounds represented by structural formula (II): both R′ are —H and m is 1 and the compounds are represented by structural formula (III):
and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I) or (II).
In another embodiment of the present invention for the compounds represented by structural formula (III):
Each Ra is independently a C1-C10 alkyl.
R″ is —H, a C1-C10 alkyl or a substituted benzyl group.
n is an integer from 1 to 6, and the remainder of the variables are as described in the immediately preceding paragraph or for structural formula (I) or (II).
In another embodiment of the present invention for compounds represented by structural formula (III): n is 1, s is 0 and R″ is —H and the compounds are represented by structural formula (IV):
with the proviso that ring C is not:
and the remainder of the variables are as described above for structural formula (I), (II) or (III).
In certain embodiments of the present invention the compounds represented by structural formula (III) or (IV) are represented by the following structural formulas:
In another embodiment of the present invention for compounds represented by structural formula (III): n is 1 and the compounds are represented by structural formula (V):
and the remainder of the variables are as described above for structural formula (I), (II) or (III).
In another embodiment of the present invention for compounds represented by structural formula (III): s is 0 and the compounds are represented by structural formula (VI):
and the remainder of the variables are as described above for structural formula (I), (II) or (III).
In another embodiment of the present invention for compounds represented by structural formula (III): R″ is —H and the compounds are represented by structural formula (VII):
and the remainder of the variables are as described above for structural formula (I), (II) or (III).
In certain embodiments of the present invention the compounds represented by structural formula (III), (V), (VI) or (VII) are represented by the following structural formulas:
In another embodiment of the present invention for compounds represented by structural formula (III): R″ is —H and n is 1 and the compounds are represented by structural formula (VIII):
and the remainder of the variables are as described above for structural formula (I), (II) or (III).
In certain embodiments of the present invention the compounds represented by structural formula (III) or (VIII) are represented by the following structural formulas:
In another embodiment of the present invention for compounds represented by structural formula (III): s is 0 and R″ is —H and the compounds are represented by structural formula (IX):
and the remainder of the variables are as described above for structural formula (I), (II) or (III).
In certain embodiments of the present invention the compounds represented by structural formula (III) or (IX) are represented by the following structural formulas:
In another embodiment of the present invention for compounds represented by structural formula (III): s is 0 and n is 0 and the compounds are represented by structural formula (X):
and the remainder of the variables are as described above for structural formula (I), (II) or (III).
In certain embodiments of the present invention the compounds represented by structural formula (III) or (X) are represented by the following structural formulas:
In another embodiment of the present invention the compound is represented by:
The term “alkyl” as used herein means a saturated straight-chain, branched or cyclic hydrocarbon. When straight-chained or branched, an alkyl group is typically C1-C20, more typically C1-C10; when cyclic, an alkyl group is typically C3-C12, more typically C3-C7. Examples of alkyl groups include methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl and tent-butyl and 1,1-dimethylhexyl.
The term “alkoxy” as used herein is represented by —OR**, wherein R** is an alkyl group as defined above.
The term “carbonyl” as used herein is represented by —C(═O)R**, wherein R** is an alkyl group as defined above.
The term “alkoxycarbonyl” as used herein is represented by —C(═O)OR**, wherein R** is an alkyl group as defined above.
The term “aromatic group” includes carbocyclic aromatic rings and heteroaryl rings. The term “aromatic group” may be used interchangeably with the terms “aryl”, “aryl ring” “aromatic ring”, “aryl group” and “aromatic group”.
Carbocyclic aromatic ring groups have only carbon ring atoms (typically six to fourteen) and include monocyclic aromatic rings such as phenyl and fused polycyclic aromatic ring systems in which a carbocyclic aromatic ring is fused to one or more aromatic rings (carbocyclic aromatic or heteroaromatic). Examples include 1-naphthyl, 2-naphthyl, 1-anthracyl and 2-anthracyl, Also included within the scope of the term “carbocyclic aromatic ring”, as it is used herein, is a group in which an aromatic ring is fused to one or more non-aromatic rings (carbocyclic or heterocyclic), such as in an indanyl, phthalimidyl, naphthimidyl, phenanthridinyl, or tetrahydronaphthyl.
The term “heteroaryl”, “heteroaromatic”, “heteroaryl ring”, “heteroaryl group” and “heteroaromatic group”, used alone or as part of a larger moiety as in “heteroaralkyl” refers to heteroaromatic ring groups having five to fourteen members, including monocyclic heteroaromatic rings and polycyclic aromatic rings in which a monocyclic aromatic ring is fused to one or more other aromatic ring (carbocyclic or heterocyclic). Heteroaryl groups have one or more ring heteroatoms. Examples of heteroaryl groups include 2-furanyl, 3-furanyl, N-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, oxadiazolyl, oxadiazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, N-pyrazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, N-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 3-pyridazinyl, 4-pyridazinyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, triazolyl, tetrazolyl, 2-thienyl, 3-thienyl, carbazolyl, benzothienyl, benzofuranyl, indolyl, quinolinyl, benzothiazole, benzooxazole, benzimidazolyl, isoquinolinyl and isoindolyl. Also included within the scope of the term “heteroaryl”, as it is used herein, is a group in which an aromatic ring is fused to one or more non-aromatic rings (carbocyclic or heterocyclic).
The term non-aromatic heterocyclic group used alone or as part of a larger moiety refers to non-aromatic heterocyclic ring groups having three to fourteen members, including monocyclic heterocyclic rings and polycyclic rings in which a monocyclic ring is fused to one or more other non-aromatic carbocyclic or heterocyclic ring or aromatic ring (carbocyclic or heterocyclic). Heterocyclic groups have one or more ring heteroatoms, and can be saturated or contain one or more units of unsaturation. Examples of heterocyclic groups include piperidinyl, piperizinyl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, tetrahydroquinolinyl, inodolinyl, isoindolinyl, tetrahydrofuranyl, oxazolidinyl, thiazolidinyl, dioxolanyl, dithiolanyl, tetrahydropyranyl, dihydropyranyl, azepanyl and azetidinyl
The term “heteroatom” means nitrogen, oxygen, or sulfur and includes any oxidized form of nitrogen and sulfur, and the quaternized form of any basic nitrogen. Also the term “nitrogen” includes a substitutable nitrogen of a heteroaryl or non-aromatic heterocyclic group. As an example, in a saturated or partially unsaturated ring having 0-3 heteroatoms selected from oxygen, sulfur or nitrogen, the nitrogen may be N (as in 3,4-dihydro-2H-pyrrolyl), NH (as in pyrrolidinyl) or NR″ (as in N-substituted pyrrolidinyl), wherein R″ is a suitable substituent for the nitrogen atom in the ring of a non-aromatic nitrogen-containing heterocyclic group, as defined below. Preferably the nitrogen is unsubstituted.
As used herein the term non-aromatic carbocyclic ring as used alone or as part of a larger moiety refers to a non-aromatic carbon containing ring which can be saturated or contain one or more units of unsaturation, having three to fourteen atoms including monocyclic and polycyclic rings in which the carbocyclic ring can be fused to one or more non-aromatic carbocyclic or heterocyclic rings or one or more aromatic (carbocyclic or heterocyclic) rings
An optionally substituted aryl group as defined herein may contain one or more substitutable ring atoms, such as carbon or nitrogen ring atoms, Examples of suitable substituents on a substitutable ring carbon atom of an aryl group include halogen (e.g., —Br, Cl, I and F), —OH, C1-C4 alkyl, C1-C4 haloalkyl, —NO2, C1-C4 alkoxy, C1-C4 haloalkoxy, —CN, —NH2, C1-C4 alkylamino, C1-C4 dialkylamino, —C(O)NH2, —C(O)NH(C1-C4 alkyl), —C(O)(C1-C4 alkyl), —OC(O)(C1-C4 alkyl), —OC(O)(aryl), —OC(O)(substituted aryl), —OC(O)(aralkyl), —OC(O)(substituted aralkyl), —NHC(O)H, —NHC(O)(C1-C4 alkyl), —C(O)N(C1-C4 alkyl)2, —NHC(O)O—(C1-C4 alkyl), —C(O)OH, —C(O)O—(C1-C4 alkyl), —NHC(O)NH2, —NHC(O)NH(C1-C4 alkyl), —NHC(O)N(C1-C4 alkyl)2, —NH—C(═NH)NH2, —SO2NH2—SO2NH(C1-C3alkyl), —SO2N(C1-C3alkyl)2, NHSO2H, NHSO2(C1-C4 alkyl) and optionally substituted aryl. Preferred substituents on aryl groups are as defined throughout the specification, In certain embodiments aryl groups are unsubstituted.
Examples of suitable substituents on a substitutable ring nitrogen atom of an aryl group include C1-C4 alkyl, NH2, C1-C4 alkylamino, C1-C4 dialkylamino, —C(O)NH2, —C(O)NH(C1-C4 alkyl), —C(O)(C1-C4 alkyl), —CO2R**, —C(O)C(O)R**, —C(O)CH3, —C(O)OH, —C(O)O—(C1-C4 alkyl), —SO2NH2—SO2NH(C1-C3alkyl), —SO2N(C1-C3alkyl)2, NHSO2H, NHSO2(C1-C4 alkyl), —C(═S)NH2, —C(═S)NH(C1-C4 alkyl), —C(—S)N(C1-C4 alkyl)2, —C(NH)—N(H)2, —C(—NH)—NH(C1-C4 alkyl) and —C(═NH)—N(C1-C4 alkyl)2.
An optionally substituted alkyl group or non-aromatic carbocyclic or heterocyclic group as defined herein may contain one or more substituents. Examples of suitable substituents for an alkyl group include those listed above for a substitutable carbon of an aryl and the following: ═O, ═S, ═NNHR**, ═NN(R**)2, —NNHC(O)R**, —NNHCO2 (alkyl), ═NNHSO2 (alkyl), ═NR**, Spiro cycloalkyl group or fused cycloalkyl group. R** in each occurrence, independently is —H or C1-C6 alkyl. Preferred substituents on alkyl groups are as defined throughout the specification. In certain embodiments optionally substituted alkyl groups are unsubstituted.
A “spiro cycloalkyl” group is a cycloalkyl group which shares one ring carbon atom with a carbon atom in an alkylene group or alkyl group, wherein the carbon atom being shared in the alkyl group is not a terminal carbon atom.
In yet another embodiment, the present invention is a method of producing a compound described herein. The method comprises the steps of combining a phenol derivative, an amine and an aldehyde in the presence of a solvent, wherein the phenol derivative comprises at least one unsubstituted ring-carbon atom. Refluxing the combination of the phenol derivative, amine and aldehyde to produce the compound, and isolating the compound.
In certain embodiments of the present invention, the phenol derivative is represented by the following structural formula:
Each Rc is independently an optionally substituted alkyl or optionally substituted alkoxycarbonyl. R′ is —H or an optionally substituted alkyl. u is an integer from 1 to 4. Additional values for these variables are as described above. In one embodiment the phenol derivative is selected from:
In another embodiment, the amine is represented by the following structural formula:
Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl. Each R′ is independently —H or an optionally substituted alkyl. n is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. Additional values for these variables are as described above.
In certain embodiments the aldehyde used in the methods of the present invention is selected from the group consisting of paraformaldehyde, formaldehyde, butylaldehyde and nonaldehyde.
In certain embodiments the solvent used in the methods of the present invention is selected from the group consisting of methanol, butanol, ethanol and toluene.
In certain embodiments of the present invention after combining the amine, aldehyde and phenol derivative in a suitable solvent the combination is refluxed for between 1 and 48 hours, between 6 and 32 hours or between 12 and 24 hours with optional stirring. In certain embodiments the combination is refluxed at a temperature between 20 and 250° C., between 60 and 180° C. or between 100 and 120° C.
In certain embodiments of the present invention equimolar amounts of the phenol derivative and the amine are combined. In certain embodiments of the present invention the phenol derivative and the amine are combined an a 1:0.5, 1:1.2, 1:1.5, 1:1.0 molar ratio of phenol derivative:amine.
The following schemes illustrate particular embodiments of this method:
Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.
Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.
Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.
Ro is H, optionally substituted alkyl, or optionally substituted alkoxycarbonyl, all of the remainder of the variables are as described above.
In one embodiment of the present invention the following schemes illustrate the methods described above:
The variables R and R1-8 described herein correspond to the variables described above for structural formulas (I) through (X) as follows R1-4 are equivalent to Rb, R5-8 are equivalent to Rc, R is equivalent to Ra, and n and m are the same.
In yet another embodiment the present invention is a method of producing a compound described herein. The method comprises the steps of combining an amino-phenol derivative with an amine in the presence of a solvent. Refluxing the combination to produce the compound, and isolating the compound.
In certain embodiments of the present invention the amino-phenol derivative is represented by the following structural formula:
Each Rc is independently an optionally substituted alkyl or an optionally substituted alkoxycarbonyl. R′ is —H or an optionally substituted alkyl. R** is an optionally substituted alkyl. o is an integer from 1 to 10. u is an integer from 1 to 4. Additional values for these variables are as described above. In another embodiment the amino-phenol is selected from the group consisting of:
In another embodiment, the amine is represented by the following structural formula:
Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl, Each R′ is independently —H or an optionally substituted alkyl. In certain embodiments one R′ is —H—H and the second R′ is —H or an optionally substituted alkyl, n is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. Additional values for these variables are as described above.
In certain embodiments, in the methods of the present invention the solvent is selected from the group consisting of toluene, methanol, ethanol and butanol.
In certain other embodiments of the present invention after combining the amine and amino-phenol derivative in a suitable solvent the combination is refluxed at a temperature between 50 and 180° C., between 90 and 130° C., between 100 and 110° C. In certain embodiments, the combination is refluxed for between 1 and 48 hours, between 6 and 36 hours, between 12 and 24 hours or between 18 and 20 hours.
In certain embodiments of the present invention equimolar amounts of the amino-phenol derivative and the amine are combined. In certain embodiments of the present invention the amino-phenol derivative and the amine are combined an a 1:0.5, 1:1.2, 1:1.5, 1:1.0 molar ratio of amino-phenol derivative:amine.
In one embodiment the above method can be conducted in one step and can be conducted without catalyst. The process can be conducted by mixing two starting components in a suitable solvent and heating the reaction mixture to reflux as shown in Scheme E:
The variables are as described above.
In one embodiment, the above method involves mixing of sterically hindered phenolic acid derivatives, preferably 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol with substituted amines e.g., N-phenyl-1,4-phenylene-diamine in a suitable solvent. The solvent can be a single solvent or mixture of two solvents. In another embodiment, the solvent is toluene.
One embodiment of the present invention is directed to combining equimolar amounts of the starting components, e.g., 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol and N-phenyl-1,4-phenylene-diamine, in toluene and refluxing the reaction mixture at, e.g., 100° C.
In certain embodiment the methods of the present invention are simple, efficient, economical and can be conducted without catalyst.
In certain other embodiments in the methods of the present invention, when solvent is used it can be recycled by separating the solvents from the reaction mixture using distillation.
In one embodiment, the present invention relates to a process or processes for the preparation of macromolecule antioxidants represented by Structural Formula I:
The disclosed synthesis of macromolecules (I) can be conducted in one step and can be conducted without catalyst. The process can be conducted by mixing two starting components in a suitable solvent and heating the reaction mixture to reflux as shown in Scheme 1.
The disclosed process can involve mixing of sterically hindered phenolic acid derivatives, preferably 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (III) with substituted amines e.g., N-phenyl-1,4-phenylene-diamine (II) in a suitable solvent. The solvent can be a single solvent or mixture of two solvents. The preferred solvent for the process can be toluene. The preferred method can be mixing of equimolar amounts of the starting components, e.g., 2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol and N-phenyl-1,4-phenylene-diamine, in toluene and refluxing the reaction mixture at, e.g., 100° C. The disclosed process can be simple, efficient, economical and can be conducted without catalyst. Further, when solvent is used in the process, it can be recycled by separating the solvents from the reaction mixture using distillation Moreover, the above mentioned reaction can also be performed under solvent-less conditions, at 100-180° C., preferably at 110° C.
In yet another embodiment the present invention is a method of producing a compound described herein. The method comprises the steps of combining a phenolic-carbonyl derivative represented by the following structural formula:
with an amine in the presence of a solvent. Refluxing the combination of phenolic-carbonyl and amine to produce a schiff's base. Reducing the schiff's base with a reducing agent to produce the compound, and isolating the compound. o is an integer from 0 to 10. R* is —H or an optionally substituted alkyl. Additional values for the variables are as described above. In certain embodiments the phenolic carbonyl is selected from the group comprising:
In another embodiment, the amine is represented by the following structural formula:
Each Ra is independently an optionally substituted alkyl. Each Rb is independently an optionally substituted alkyl. Each R′ is independently —H or an optionally substituted alkyl. n is an integer from 1 to 10. s is an integer from 0 to 5. t is an integer from 0 to 4. Additional values for these variables are as described above.
In certain embodiments of the present invention the solvent is selected from the group consisting of toluene, methanol, ethanol and butanol.
In certain other embodiments of the present invention after combining the amine and phenolic-carbonyl derivative in a suitable solvent the combination is refluxed at a temperature between 50 and 180° C., between 60 and 130° C., between 70 and 110° C. In certain embodiments, the combination is refluxed for between 1 and 48 hours, between 6 and 36 hours, between 12 and 24 hours or between 18 and 20 hours.
In certain embodiments of the present invention equimolar amounts of the phenol-carbonyl derivative and the amine are combined. In certain embodiments of the present invention the amino-phenol derivative and the amine are combined an a 1:0.5, 1:1.2, 1:1.5, 1:1.0 molar ratio of phenol-carbonyl derivative:amine
In certain embodiment the reducing agent is selected from the groups consisting of sodium borohydride, sodium cyanoborohydride and lithium aluminum hydride. In certain other embodiments reduction takes place via catalytic hydrogenation. In certain embodiments the catalytic hydrogenation agents are Pd—C or Raney Ni.
In yet another embodiment the present invention is a method of producing a compound described herein. The method comprises the steps of combining a formaldehyde-sodium bisulfite adduct with an amine to produce a methylsulfonate sodium salt in an aqueous media. Followed by the nucleophilic displacement of the sulfonate group with sodium or potassium salt of a phenol derivative, in an aqueous media, to produce the compound, and finally isolating the compound. In certain embodiments the nucleophilic displacement is promoted by base or catalyzed base. In certain embodiments, both combination steps are carried out in an aqueous media.
In certain embodiments the formaldehyde-sodium bisulfite adduct is HO—CH2—SO3Na.
In certain embodiments the methylsulfonate sodium salt is 4-(phenylamino)phenylamino methylsulfonate sodium salt.
In certain embodiments, the phenol derivative and amine are as described above.
In certain embodiments, the aqueous media is water.
In certain embodiments, the base is sodium hydroxide or potassium hydroxide.
In one embodiments of the present invention, the compound is not:
The compounds of the present invention can be used as antioxidants to inhibit oxidation of an oxidizable material. Such as, for example to increase the shelf life of an oxidizable material.
The antioxidant compounds of the present invention can be employed to inhibit the oxidation of an oxidizable material, for example by contacting the material with an antioxidant compound made by the methods of the present invention.
For purposes of the present invention, a method of “inhibiting oxidation” is a method that inhibits the propagation of a free radical-mediated process. Free radicals can be generated by heat, light, ionizing radiation, metal ions and some proteins and enzymes. Inhibiting oxidation also includes inhibiting reactions caused by the presence of oxygen, ozone or another compound capable of generating these gases or reactive equivalents of these gases.
As used herein the term “oxidizable material” is any material which is subject to oxidation by free-radicals or oxidative reaction caused by the presence of oxygen, ozone or another compound capable of generating these gases or reactive equivalents thereof. In particular the oxidizable material is a lubricant or a mixture of lubricants.
The shelf life of many materials and substances contained within the materials, such as packaging materials, are enhanced by the presence of the antioxidants of the present invention. The addition of an antioxidant of the present invention to a packaging material is believed to provide additional protection to the product contained inside the package. In addition, the properties of many packaging materials themselves, particularly polymers, are enhanced by the presence of an antioxidant regardless of the application (i.e., not limited to use in packaging). Common examples of packaging materials include paper, cardboard and various plastics and polymers. A packaging material can be coated with an antioxidant (e.g., by spraying the antioxidant or by applying as a thin film coating), blended with or mixed with an antioxidant, or otherwise have an antioxidant present within it. In one example, a thermoplastic such as polyethylene, polypropylene or polystyrene can be melted in the presence of an antioxidant in order to minimize its degradation during the polymer processing.
The lifetime of lubricants, lubricant oils, mixtures thereof and compositions comprising lubricants and lubricant oils in general can be improved by contacting the lubricant, lubricant oil, mixtures thereof or composition comprising the lubricant or lubricant oil or mixtures thereof with compounds of the present invention, as described herein.
As used here, the terms “lubricants” and “lubricant oils” can be used interchangeably. Examples of lubricants suitable for use in the compositions and methods of the present invention include, but are not limited to: i) petroleum based oils (Group I, II and III), ii) synthetic oils (Group IV) and iii) biolubricant oils (vegetable oils such as canola, soybean, corn oil etc.). Group I oils, as defined herein are solvent refined base oils. Group II oils, as defined herein are modern conventional base oils made by hydrocracking and early wax isomerization, or hydroisomerization technologies and have significantly lower levels of impurities than Group I oils. Group III oils, as defined herein are unconventional base oils. Groups I-III differ in impurities, and viscosity index as is shown in Kramer et al. “The Evolution of Base Oil Technology” Turbine Lubrication in the 21st Century ASTM STP #1407 W. R. Herguth and T. M. Wayne, Eds., American Society for Testing and Materials, West Conshohocken, Pa., 2001 the entire contents of which are incorporated herein by reference. Group IV oils as defined herein are “synthetic” lubricant oils, including for example, poly-alpha olefins (PAOs). Biolubricants as defined herein are lubricants which contain at least 51% biomaterial (see Scott Fields, Environmental Health Perspectives, volume 111, number 12, September 2003, the entire contents of which are incorporated herein by reference). Other examples of lubricant oils cane be found in Melvyn F. Askew “Biolubricants-Market Data Sheet” IENICA, August 2004 (as part of the IENICA workstream of the IENICA-INFORRM project); Taylor et al. “Engine lubricant Trends Since 1990” paper accepted for publication in the Proceedings I. Mech. E. Part J, Journal of Engineering Tribology, 2005 (Vol. 219 p 1-16); and Desplanches et al. “Formulating Tomorrow's Lubricants” page 49-52 of The Paths to Sustainable Development, part of special report published in October 2003 by Total; the entire contents of each of which are incorporated herein by reference. Biolubricants are often but not necessarily, based on vegetable oils. Vegetable derived, for example, from rapeseed, sunflower, palm and coconut can be used as biolubricants. They can also be synthetic esters which may be partly derived from renewable resources. They can be made from a wider variety of natural sources including solid fats and low grade or waste materials such as tallows. Biolubricants in general offer rapid biodegradability and low environmental toxicity.
As used herein, Group I, II and III oils are petroleum base stock oil. The petroleum industry differentiates their oil based on viscosity index and groups them as Group I, II and III.
In certain embodiments of the present invention, 50% to 20% by weight of the antioxidants of the present invention are added to lubricant oils. In certain other embodiments of the present invention, 10% to 5% by weight of the antioxidants of the present invention are added to lubricant oils. In certain other embodiments of the present invention, 0.1% to 2% by weight of the antioxidants of the present invention are added to lubricant oils. In certain other embodiments of the present invention, 0.001% to 0.5% by weight of the antioxidants of the present invention are added to lubricant oils. This percentage varies depending upon their end application and type of the base oil.
In certain embodiments of the present invention the antioxidants of the present invention are usually added to lubricant oils with stirring at between 0 and 100° C., between 20 and 80° C. or between 40-60° C.
The macromolecules of the present invention can also be made by alkylation of substituted amines, most preferably, N-phenyl-1,4-phenylene-diamine (II) in a suitable solvent by benzyl halides, e.g., preferably 3,5-di-tert-butyl-4-hydroxy benzyl chloride (IV) or 3,5-di-tert-butyl-4-hydroxy benzyl bromide (V) as shown in Scheme 2.
2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (26.3 g) and N-Phenyl-1,4-phenylene-diamine (18.4 g) were dissolved in 50 ml toluene. The reaction mixture was refluxed at 100° C. using a Dean Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The product (A) was characterized using spectroscopic techniques such as high resolution 1H NMR, 13C NMR and FT-IR.
Macromolecule A was mixed with oil at 60° C. for 5-15 minutes at 200 ppm in petroleum based group II base stock oil and polyol based Group V base stock oils. It was tested using differential scanning calorimetry (DSC). Its Oxidative Induction Time (OIT) was also compared with commercially used antioxidants 2,6-di-tert-butyl-phenol, Naugalube APAN (PANA) and Vanlube 81 (DODP).
2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (3 g) and N-Phenyl-1,4-phenylene-diamine (2 g) were dissolved in 100 ml toluene. The reaction mixture was refluxed at 100° C. using a Dean's Stark apparatus equipped with a condenser. The reaction was monitored by thin layer chromatography. After completion, the solvent was removed by distillation and the resultant mixture was purified by column chromatography. The purified compound was characterized by spectroscopic techniques.
2,6-di-tert-butyl-4-(dimethyl-aminomethyl)phenol (32 g) and N-Phenyl-1,4-phenylene-diamine (18.4 g) were dissolved in 50 ml toluene. The reaction mixture was refluxed at 100° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The purified compound was characterized by spectroscopic techniques.
2,6-di-tort-butyl phenol (10.3 g), paraformaldehyde (1.8 g) and N-hexyl-Phenyl-1,4-phenylene-diamine (16.08 g) were dissolved in 75 ml methanol. The reaction mixture was refluxed at 70° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The purified compound was characterized by spectroscopic techniques.
2-methyl, 6-tert-butyl phenol (16.4 g), paraformaldehyde (3.6 g) and N-Phenyl-1,4-phenylene-diamine (22 g) were dissolved in 50 ml methanol, The reaction mixture was refluxed at 70° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration and purified by column chromatography. The purified compound was characterized by spectroscopic techniques.
2,4-di-tert-butyl phenol (20.6 g), paraformaldehyde (3.6 g) and N-Phenyl-1,4-phenylene-diamine (22 g) were dissolved in 50 ml methanol. The reaction mixture was refluxed at 70° C. using a Dean's Stark apparatus equipped with a condenser. After completion, the solvent was removed by distillation and ice-cold water added and refluxed. The reaction mixture was cooled to room temperature and product was isolated by filtration. The purified compound was characterized by spectroscopic techniques.
Macromolecules V and A were tested for their performance in lubricant oils and polymers. The macromolecules were mixed in oil with stirring at 60° C. for 5-15 mins at 200 ppm in petroleum based Group II base stock and polyol based Group V base stock oils. The performance of these antioxidants were evaluated in lubricant base oil stocks including Group II using the DSC technique for determining their oxidation induction times measured in minutes (OTT) at 200° C. The OITs of the antioxidants having structures V and A were compared with commercial antioxidants [L57: Ciba's Irganox L57, 6PPD: N-hexyl phenyl-1,4-phenylene diamine CAS # 793-24-8)]. The results are shown in
Macromolecule I, II, X and VIII are mixed in oil with stirring at 60° C. for 5-15 mins at 200 ppm in petroleum based Group II base stock and polyol based Group V base stock oils. The performance of these antioxidants is evaluated in lubricant base oil stocks including Group II using the DSC technique for determining their oxidation induction times measured in minutes (OTT) at 200° C. The OITs of these novel antioxidants having structures I, II, X, XVIII is compared with commercial antioxidants [L57: Ciba's Irganox L57, dioctylated diphenyl amine (DODP, CAS# 68411-46-1); 6PPD: N-hexyl phenyl-1,4-phenylene diamine CAS # 793-24-8)].
The summary of performance of antioxidants I, II, V, X, XVIII and A and their comparison with commercial antioxidants L 57 and 6PPD in synthetic polyol ester based oil is shown in Table 1. The macromolecules were mixed in oil with stirring at 60° C. for 5-15 mins at 200 ppm in petroleum based Group II base stock and polyol based Group V base stock oils. Table 1, shows the superior performance of these compounds.
The performance of antioxidants I, II, V, X, XVIII and A were also evaluated in polyolefins especially in polypropylene (PP) and are compared with the performance of commercially used antioxidant, Irganox 1010 (from Ciba, CAS # 6683-19-8).
10 g of the antioxidant V was added to 90 g of Group II lubricant oil base stock in a beaker. The resultant mixture was stirred for 15 mins in a oil bath maintained at 60° C. to give a homogenous solution. This homogenous solution was used for evaluation. This solubility is much higher than the typical industry standards of 1-2%.
The entire contents of each of the following are incorporated herein by reference.
While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in faun and details may be made therein without departing from the scope of the invention.
Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to specific embodiments of the invention described specifically herein. Such equivalents are intended to be encompassed in the scope of the following claims.
This application is a divisional of U.S. application Ser. No. 11/360,020, filed Feb. 22, 2006 now U.S. Pat. No. 7,799,948, which claims the benefit of U.S. Provisional Application No. 60/655,169, filed on Feb. 22, 2005. The entire teachings of the above applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3116305 | Morris et al. | Dec 1963 | A |
3294836 | Peterson et al. | Dec 1966 | A |
3441545 | Blatz et al. | Apr 1969 | A |
3459704 | Peterson et al. | Aug 1969 | A |
3557245 | Phillips et al. | Jan 1971 | A |
3632785 | Bornstein | Jan 1972 | A |
3645970 | Kleiner | Feb 1972 | A |
3649667 | Song et al. | Mar 1972 | A |
3655831 | Friedman | Apr 1972 | A |
3870680 | Schurdak | Mar 1975 | A |
3907939 | Robin et al. | Sep 1975 | A |
3953402 | Kline | Apr 1976 | A |
3965039 | Chaplits et al. | Jun 1976 | A |
3983091 | Gloth et al. | Sep 1976 | A |
3994828 | Zaffaroni | Nov 1976 | A |
3996160 | Dale et al. | Dec 1976 | A |
3996198 | Wang et al. | Dec 1976 | A |
4054676 | Weinshenker et al. | Oct 1977 | A |
4094857 | Wolfe, Jr. | Jun 1978 | A |
4096319 | Willette et al. | Jun 1978 | A |
4097464 | Kline | Jun 1978 | A |
4098829 | Weinshenker et al. | Jul 1978 | A |
4107144 | Russell et al. | Aug 1978 | A |
4136055 | Lyons | Jan 1979 | A |
4202816 | Moser et al. | May 1980 | A |
4205151 | Dale et al. | May 1980 | A |
4213892 | Scott | Jul 1980 | A |
4219453 | Sakurai et al. | Aug 1980 | A |
4267358 | Hechenbleikner et al. | May 1981 | A |
4281192 | Jacquet et al. | Jul 1981 | A |
4283572 | Klicker | Aug 1981 | A |
4317933 | Parker | Mar 1982 | A |
4341879 | Sugio et al. | Jul 1982 | A |
4355148 | Layer et al. | Oct 1982 | A |
4377666 | Farrar | Mar 1983 | A |
4380554 | Serres, Jr. | Apr 1983 | A |
4447657 | Firth et al. | May 1984 | A |
4465871 | Firth et al. | Aug 1984 | A |
4510296 | Hergenrother | Apr 1985 | A |
4511491 | Ishii et al. | Apr 1985 | A |
4634728 | Dunski et al. | Jan 1987 | A |
4690995 | Keskey et al. | Sep 1987 | A |
4761247 | Rei et al. | Aug 1988 | A |
4824929 | Arimatsu et al. | Apr 1989 | A |
4849503 | Cotter et al. | Jul 1989 | A |
4855345 | Rosenberger et al. | Aug 1989 | A |
4857596 | MacLeay et al. | Aug 1989 | A |
4870214 | Mina et al. | Sep 1989 | A |
4894263 | Dubois et al. | Jan 1990 | A |
4897438 | Kikuchi et al. | Jan 1990 | A |
4900671 | Pokora et al. | Feb 1990 | A |
4925591 | Nakauchi et al. | May 1990 | A |
4968759 | Kikuchi et al. | Nov 1990 | A |
4977004 | Bettle, III et al. | Dec 1990 | A |
4981917 | MacLeay et al. | Jan 1991 | A |
4994628 | Goddard et al. | Feb 1991 | A |
5013470 | Benfaremo | May 1991 | A |
5017727 | Olivier | May 1991 | A |
5082358 | Tabata et al. | Jan 1992 | A |
5102962 | Kikuchi et al. | Apr 1992 | A |
5117063 | Stern et al. | May 1992 | A |
5143828 | Akkara et al. | Sep 1992 | A |
5155153 | Neri et al. | Oct 1992 | A |
5185391 | Stokich, Jr. | Feb 1993 | A |
5185407 | Wong | Feb 1993 | A |
5188953 | Johnson et al. | Feb 1993 | A |
5191008 | Frost et al. | Mar 1993 | A |
5196142 | Mollet et al. | Mar 1993 | A |
5206303 | Tse et al. | Apr 1993 | A |
5207939 | Farng et al. | May 1993 | A |
5274060 | Schadeli | Dec 1993 | A |
5278055 | Cyrus, Jr. et al. | Jan 1994 | A |
5304589 | Davidson et al. | Apr 1994 | A |
5320889 | Bettle, III | Jun 1994 | A |
5449715 | Plochocka et al. | Sep 1995 | A |
5498809 | Emert et al. | Mar 1996 | A |
RE35247 | Cyrus, Jr. et al. | May 1996 | E |
5516856 | Sanchez | May 1996 | A |
5541091 | Wheeler et al. | Jul 1996 | A |
5565300 | Uenishi et al. | Oct 1996 | A |
5574118 | Olivier | Nov 1996 | A |
5652201 | Papay et al. | Jul 1997 | A |
5739341 | Dubs et al. | Apr 1998 | A |
5834544 | Lin et al. | Nov 1998 | A |
5837798 | Hutchings et al. | Nov 1998 | A |
5869592 | Gagne et al. | Feb 1999 | A |
5911937 | Hekal | Jun 1999 | A |
5994498 | Tripathy et al. | Nov 1999 | A |
6018018 | Samuelson et al. | Jan 2000 | A |
6046263 | Rasberger et al. | Apr 2000 | A |
6096695 | Lam et al. | Aug 2000 | A |
6096859 | Akkara et al. | Aug 2000 | A |
6150491 | Akkara | Nov 2000 | A |
6232314 | Jarrott et al. | May 2001 | B1 |
6342549 | Hirose et al. | Jan 2002 | B1 |
6444450 | Akkara et al. | Sep 2002 | B2 |
6646035 | Koch et al. | Nov 2003 | B2 |
6723815 | Callaghan et al. | Apr 2004 | B2 |
6743525 | Berntsen et al. | Jun 2004 | B2 |
6770785 | Desai et al. | Aug 2004 | B1 |
6794480 | Goto et al. | Sep 2004 | B2 |
6800228 | Semen | Oct 2004 | B1 |
6828364 | Gugumus | Dec 2004 | B2 |
7132496 | Kerres et al. | Nov 2006 | B2 |
7169844 | Inokami | Jan 2007 | B2 |
7205350 | Thibaut | Apr 2007 | B2 |
7223432 | Cholli et al. | May 2007 | B2 |
7262319 | Rehm et al. | Aug 2007 | B2 |
7705176 | Cholli et al. | Apr 2010 | B2 |
20010041203 | Uno et al. | Nov 2001 | A1 |
20020007020 | Higashimura et al. | Jan 2002 | A1 |
20020128493 | Romanczyk, Jr. et al. | Sep 2002 | A1 |
20020143025 | Pratt et al. | Oct 2002 | A1 |
20020183470 | Tripathy et al. | Dec 2002 | A1 |
20030030033 | Duyck et al. | Feb 2003 | A1 |
20030078346 | Nakamura et al. | Apr 2003 | A1 |
20030091837 | Aoki | May 2003 | A1 |
20030176620 | Romanczyk, Jr. et al. | Sep 2003 | A1 |
20030191242 | Zedda et al. | Oct 2003 | A1 |
20030229196 | Braat et al. | Dec 2003 | A1 |
20030230743 | Cholli et al. | Dec 2003 | A1 |
20040015021 | Adams et al. | Jan 2004 | A1 |
20040164279 | Stevenson et al. | Aug 2004 | A1 |
20040180994 | Pearson et al. | Sep 2004 | A1 |
20040186167 | Dou et al. | Sep 2004 | A1 |
20040186214 | Li et al. | Sep 2004 | A1 |
20040198875 | Kaprinidis et al. | Oct 2004 | A1 |
20040214935 | Cholli et al. | Oct 2004 | A1 |
20050170978 | Migdal et al. | Aug 2005 | A1 |
20050209379 | Botkin et al. | Sep 2005 | A1 |
20050238789 | Cholli et al. | Oct 2005 | A1 |
20050242328 | Baranski | Nov 2005 | A1 |
20060029706 | Cholli et al. | Feb 2006 | A1 |
20060040833 | Al-Akhdar et al. | Feb 2006 | A1 |
20060041087 | Cholli | Feb 2006 | A1 |
20060041094 | Cholli | Feb 2006 | A1 |
20060128929 | Yang et al. | Jun 2006 | A1 |
20060128930 | Dhawan et al. | Jun 2006 | A1 |
20060128931 | Kumar et al. | Jun 2006 | A1 |
20060128939 | Kumar et al. | Jun 2006 | A1 |
20060154818 | Destro et al. | Jul 2006 | A1 |
20060189820 | Rehm et al. | Aug 2006 | A1 |
20060189824 | Kumar et al. | Aug 2006 | A1 |
20060208227 | Shiraki | Sep 2006 | A1 |
20060233741 | Kumar et al. | Oct 2006 | A1 |
20070010632 | Kaplan et al. | Jan 2007 | A1 |
20070106059 | Cholli et al. | May 2007 | A1 |
20070135539 | Cholli et al. | Jun 2007 | A1 |
20070149660 | Kumar et al. | Jun 2007 | A1 |
20070154430 | Cholli et al. | Jul 2007 | A1 |
20070154608 | Cholli et al. | Jul 2007 | A1 |
20070154720 | Cholli et al. | Jul 2007 | A1 |
20070161522 | Cholli et al. | Jul 2007 | A1 |
20080249335 | Cholli et al. | Oct 2008 | A1 |
20080293856 | Kumar et al. | Nov 2008 | A1 |
20080311065 | Cholli | Dec 2008 | A1 |
20090184294 | Cholli et al. | Jul 2009 | A1 |
Number | Date | Country |
---|---|---|
111291 | Jun 1964 | CS |
197 47 644 | May 1999 | DE |
198 43 875 | Mar 2000 | DE |
0 181 023 | May 1986 | EP |
0 289 077 | Nov 1988 | EP |
0 358 157 | Mar 1990 | EP |
0 404 039 | Dec 1990 | EP |
0 618 203 | Oct 1994 | EP |
0 688 805 | Dec 1995 | EP |
1 067 144 | Jan 2001 | EP |
1 468 968 | Oct 2004 | EP |
2 183 973 | Dec 1973 | FR |
1042639 | Sep 1964 | GB |
1 283 103 | Jul 1972 | GB |
1 320 169 | Jun 1973 | GB |
1 372 042 | Oct 1974 | GB |
1 389 442 | Apr 1975 | GB |
1 469 245 | Apr 1977 | GB |
1 482 649 | Aug 1977 | GB |
69002715 | Jan 1966 | JP |
43016392 | Jul 1968 | JP |
44024274 | Oct 1969 | JP |
44028850 | Nov 1969 | JP |
45 2980 | Jan 1970 | JP |
49 29339 | Mar 1974 | JP |
57085366 | May 1982 | JP |
59025814 | Feb 1984 | JP |
59197447 | Nov 1984 | JP |
60-199832 | Oct 1985 | JP |
05 199858 | Aug 1993 | JP |
06135876 | May 1994 | JP |
06 247959 | Sep 1994 | JP |
08027226 | Jan 1996 | JP |
09262069 | Oct 1997 | JP |
09 328519 | Dec 1997 | JP |
09 328521 | Dec 1997 | JP |
9322784 | Dec 1997 | JP |
11-80063 | Mar 1999 | JP |
11-158103 | Jun 1999 | JP |
2003138258 | May 2003 | JP |
7 905 000 | Mar 1980 | NL |
WO 9220734 | Nov 1992 | WO |
WO 0039064 | Jul 2000 | WO |
WO 0118125 | Mar 2001 | WO |
WO 0148057 | Jul 2001 | WO |
WO 02079130 | Oct 2002 | WO |
WO 03087260 | Oct 2003 | WO |
WO 03102004 | Dec 2003 | WO |
WO 2004024070 | Mar 2004 | WO |
WO 2004050795 | Jun 2004 | WO |
WO 2005025513 | Mar 2005 | WO |
WO 2005025646 | Mar 2005 | WO |
WO 2005060500 | Jul 2005 | WO |
WO 2005070974 | Aug 2005 | WO |
WO 2005071005 | Aug 2005 | WO |
WO 2006018403 | Feb 2006 | WO |
WO 2006060801 | Jun 2006 | WO |
WO 2006104957 | Oct 2006 | WO |
WO 2008005358 | Jan 2008 | WO |
Number | Date | Country | |
---|---|---|---|
20110040125 A1 | Feb 2011 | US |
Number | Date | Country | |
---|---|---|---|
60655169 | Feb 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11360020 | Feb 2006 | US |
Child | 12854347 | US |